Document:

ex 10.2 Sunnylife Agreement

    Exhibit
      10.2

    

    Sunnylife
      Global, Inc. Agreement

    

    Exclusive
      License and Manufacturing Agreement

    

    THIS
      EXCLUSIVE LICENSE AND MANUFACTURING AGREEMENT (the “Agreement”) is entered by
      Sunnylife Global, Inc. (referred to as “Licensor” and/or “Manufacturer”), a
      corporation organized and existing under the laws of California, with its
      principal place of business at 1000 Lakes Drive, #230, West Covina, California
      91790, and AOB Biotech, Inc. (referred to as “Licensee”), a corporation
      organized and existing under the laws of California, with its principal place
      of
      business at 150 N. Santa Anita Avenue, #300, Arcadia, California 91007.
      Licensor/Manufacturer and Licensee shall be sometimes separately or collectively
      referred to as the “Party” or “Parties” in the agreement.

    

    WHEREAS,
      Licensor/Manufacturer is the owner of certain proprietary rights and interests
      to the intellectual property referred to in Paragraph 1 of this agreement and
      intellectual property has been further specified as “Licensor’s Intellectual
      Property Rights” in the attached Exhibit A.

    

    WHERAS,
      Licensee desired to be licensed for certain exclusive marketing and distribution
      rights in the licensed products using Licensor’s Intellectual Property
      Rights.

    

    NOW,
      THEREFORE in consideration of the promises and the representations, warranties
      and covenants contained herein, the Parties of this agreement agree as
      follows:

    

    
      	1.  	
              Licensor’s
                Intellectual Property
                Rights

            

    

    

    “Licensor’s
      Intellectual Property Rights”

    

    The
      “Licensor’s
      Intellectual Property Rights” refers to all formulas, inventions and all other
      proprietary rights, including but not limited to know-how, research data,
      copyrights, trade secrets, formulas, and specifications related to the
      inventions, technologies, and/or any intellectual properties commonly known
      and
      described as follows:

    

    Exhibit
      “A” Cardio Essential

    Exhibit
      “B” Joint Essential

    Exhibit
      “C” Glucose Modulator

    Exhibit
      “D” Ultra Spirit

    Exhibit
      “E” Optimal Care

    Exhibit
      “F” Menoease

    Exhibit
      “G” Age Defender

    Exhibit
      “H” Ultra-antioxidant

    
      

      More
        complete descriptions are provided for on Exhibits A through H as attached
        to
        this agreement.

      

      	1.          
               	
              Intellectual
                Property Rights

            

       

      The
        “Licensor’s
        Intellectual Property Rights” in connection with Cardio Essential refers to the
        inventions described in the U.S. Patent Application No. __________, as described
        in Exhibit A as attached to this agreement. All patent application expenses
        and
        fees will be paid for by the “Licensee.”

      

      “Licensed
        Products”

       

    

    “Licensed
      Products are defined as the products using or incorporating the Licensor’s
      Intellectual Property Rights as specifically described in Exhibits A through
      H
      as attached to this agreement.”

     

     

    
      
        
        

      

      
        -
          1
          -

        
          

        

      

      
        
        

      

    

     

    
      	2.  	
              Grant
                of Rights

            

    

    

    Licensor
      grants to Licensee the exclusive right of marketing and distribution of Licensed
      Products embodying or manufactured in accordance with the Licensor’s
      Intellectual Property Rights described above in the preceding paragraph 1 of
      this document.

    

    
      	3.  	
              Exclusive
                Manufacturer

            

    

    

    Both
      parties expressly agree that Licensor shall be the exclusive and only
      manufacturer of the licensed products to be marketed and distributed by licensee
      in the specified territory described and defined in Exhibit 1 as attached to
      this document.

    

    
      	4.  	
              Sublicense

            

    

    

    Licensee
      may sublicense the rights granted pursuant to this agreement provided the
      licensee must obtain Licensor’s prior written consent to such
      sublicense.

    

    
      	5.  	
              Territory

            

    

    

    The
      rights granted to Licensee are limited to the geographical territory as defined
      and specified in Exhibit 1 attached to this agreement.

    

    
      	6.  	
              Term

            

    

    

    This
      agreement shall commence upon the latest signature date of Licensor and Licensee
      (the “effective Date”) and upon receipt by Licensor of any initial payment as
      agreed to by both parties (the “initial Payment” of Licensee). This agreement
      shall extend for a period of 15 years (the initial Term”). Following the Initial
      Term, this agreement can be renewed by both Parties under the same terms and
      conditions for an unlimited ______________agrees to the other party’s written
      notice of its intention to renew this agreement at least ninety (90) days before
      the expiration of the current term.

    

    
      	7.  	
              Manufacturing
                price (with Royalties Fee)

            

    

    

    “Manufacturing
      Price” is defined as Licensee’s acquired cost to produce and/or manufacture the
      Licensed Products including direct materials, direct manufacturing labor,
      manufacturing overhead, packaging costs and royalties fee.

    

    
      	8.  	
              Payment
                Term

            

    

    

    Licensee
      agrees that the manufacturing Price with Royalties Fee shall be paid
      C.O.D.

    

    
      	9.  	
              Sublicensing
                Revenues

            

    

    

    In
      the
      event of any sublicense to the rights granted pursuant to this agreement,
      licensee shall pay Licensor 2% of sublicensing revenues collected by
      Licensee.

    

    
      	10.  	
              Indemnification

            

    

    

    Either
      Licensor or Licensee shall indemnify, defend or hold the other Party harmless
      from any claims actions, damages and liabilities (including reasonable
      attorney’s fees and costs), arising out of or in connection with its own
      conducts and activities.

     

     

    
      
        
        

      

      
        -
          2
          -

        
          

        

      

      
        
        

      

    

     

    
      	11.  	
              Compliance
                with Intellectual Property
                Laws

            

    

    

    Both
      Parties shall comply with the provisions of the intellectual property laws
      of
      the United States and/or any foreign jurisdiction in the Territory. All items
      of
      the Licensed Product as well as all promotional material shall bear appropriate
      proprietary notices.

    

    
      	12.  	
              Infringement
                against Third Parties

            

    

    

    In
      the
      event that either Party learns of infringements of the intellectual Property
      Rights or Licensed Products, that Party shall notify the other of the
      infringement activities without any delay. In case Licensor does not commence
      legal actions against an alleged infringer within one hundred twenty (120)
      days
      of notification by Licensee, Licensee may commence legal actions against the
      third party. Before filing any lawsuit, however, Licensee shall obtain the
      written consent of Licensor to do so and such consent shall not be unreasonably
      withheld. Licensor shall cooperate fully and in good faith with Licensee for
      the
      purpose of securing and preserving the rights to the Intellectual Property
      Rights. Any recovery (including, but not limited to, any recovery from a
      judgment, award, settlement or licensing agreement) shall be divided equally
      between the Parties after deduction on and payment of attorneys’ fees and other
      costs and expenses to the Party bring the legal action.

    

    
      	13.  	
              Confidentiality

            

    

    

    The
      Parties acknowledge that each may be furnished or have access to confidential
      information that relates to each other’s business (the “Confidential
      Information”). In the event that any Confidential Information is in written
      form, the disclosing Party shall label or stamp the materials with the word
      ”Confidential” or some similar warning. In the event the Confidential
      Information is transmitted orally, the disclosing Party shall promptly provide
      a
      writing indication that that such oral communication constituted Confidential
      Information. The Parties agree to maintain the Confidential Information
      strictest confidence for the sole and exclusive benefits of the other Party
      and
      to restrict access to such Confidential Information to persons bound by this
      agreement and only on a need-to-know basis. Neither party, without prior written
      consent of the other, shall use or otherwise disclose to others, or permit
      the
      use by others of the Confidential Information.

    

    
      	14.  	
              Termination

            

    

    

    
      	a)  	
              This
                agreement may be terminated by mutual agreement of both
                Parties

            

    

    

    
      	b)  	
              This
                agreement terminates at the end of each Term unless renewed by both
                Parties as provided for in this
                agreement

            

    

    

    
      	c)  	
              This
                agreement may be terminated upon Licensor’s ninety (90) days written
                notice at its sole discretion.

            

    

    

    
      	15.  	
              Effect
                of Termination

            

    

    

    Licensee
      may dispose of the Licensed Products covered by this agreement for a period
      of
      Thirty (30) days after termination or expiration of this agreement.

    

    
      	16.  	
              Governing
                Law

            

    

    

    This
      agreement shall be governed in accordance with the laws of the State of
      California, excluding any conflicts of law principles and rules.

     

     

    
      
        
        

      

      
        -
          3
          -

        
          

        

      

      
        
        

      

    

     

    
      	17.  	
              Dispute
                Resolution

            

    

    

    Any
      dispute arising out of or in connection with this agreement shall be resolved
      by
      a binding arbitration proceeding to be held in Los Angeles County, State of
      California. The arbitration shall be conducted on a confidential basis pursuant
      to the Commercial Arbitration Rules of the American Arbitration Association.
      Any
      decision or award as a result of any such arbitration proceeding shall be in
      writing and shall provide an explanation for all conclusions of law and fact
      and
      shall include the assessment of costs, expenses and reasonable attorneys’ fees.
      Any such arbitration shall be conducted by a neutral and impartial arbitrator
      experienced in licensing law and shall prepare a written record of the
      arbitration hearing. An award of arbitration may be confirmed and entered in
      any
      court of competent jurisdiction.

    

    
      	18.  	
              Attorneys’
                Fees

            

    

    

    The
      prevailing Party in any dispute under this agreement shall have the right to
      collect from the other Party its reasonable attorneys’ fees, expenses and costs
      incurred in enforcing this agreement.

    

    
      	19.  	
              Entire
                Agreement

            

    

    

    This
      agreement expresses the complete understanding of the Parties and supersedes
      all
      prior representations, negotiations, agreements, and understandings, whether
      written or oral. This agreement may not be altered or changed except by a
      written document executed by both Parties.

    

    
      	20.  	
              Waiver

            

    

    

    No
      waiver
      of any term, provision or condition of this agreement, whether by conduct or
      otherwise, in any one or more instances, shall be deemed to be or be construed
      as a further or continuing waiver of any such term, provision or condition,
      or
      as a waiver of any other term, provision or condition of this
      agreement.

    

    
      	21.  	
              Captions

            

    

    

    The
      caption of each paragraph is for convenience only and shall not be considered
      or
      referred to in resolving questions or interpretation.

    

    
      	22.  	
              Assignment

            

    

    

    This
      agreement shall not be assignable by any Party without the prior written consent
      of the other Party. Notwithstanding the forgoing, a Party may assign this
      agreement in whole or in part, to any subsidiary, affiliate or parent company
      of
      that Party or any successor of that Party by merger, consolidation or
      acquisition.

    

    
      	23.  	
              Severability

            

    

    

    If
      any
      term or provision of this agreement, of the application thereof to any person
      or
      circumstance, shall to any extent be found to be invalid, void or unenforceable,
      the remaining provisions and any application thereof shall, nevertheless,
      continue in full force and effect without being impaired or invalidated in
      any
      way.

    

    
      	24.  	
              Further
                Actions

            

    

    

    Each
      of
      the Parties hereto agrees to take any and all actions or provide any and all
      information and documents reasonably necessary in order to carry out the
      provisions of this agreement.

    

    
      	25.  	
              Successors
                and Assigns

            

    

    

    Except
      as
      otherwise provided herein, the provisions hereof shall be binding upon and
      shall
      inure to the benefit of the Parties hereto, their representatives, heirs,
      executors, administrators, and/or any successors or assigns as permitted by
      paragraph 24 of this agreement.

     

     

    
      
        
        

      

      
        -
          4
          -

        
          

        

      

      
        
        

      

    

     

    
      	26.  	
              Gender
                and Number

            

    

    

    As
      used
      in this agreement, the masculine gender includes the feminine and neuter, the
      feminine gender includes the masculine and neuter, the singular number includes
      the plural, the plural number includes the singular, and the term “person”
includes both a corporation and a natural person.

    

    
      	27.  	
              Counterparts

            

    

    

    This
      agreement may be executed in more than one counterpart and all the counterparts
      signed in the aggregate by both Parties shall constitute a single original
      instrument.

    

    
      	28.  	
              Attachments
                and Exhibits

            

    

    

    The
      Parties agree and acknowledge that all attachments, exhibits and/or schedules
      referred to in this agreement are hereby incorporated into this agreement by
      this reference.

    

    

    IN
      WITNESS THEREOF, the parties hereto have executed this agreement as of the
      dates
      specified below.

    

    

    
      	
              LICENSOR

            	 	
              LICENSEE

            
	
              Sunnylife
                Global, Inc.

            	 	
              AOB
                Biotech, Inc.

            
	 	 	 
	
              By:
                /s/
                Richard Lo

            	 	
              By:
                /s/ Nelson Liao

            
	
                        
                  Richard Lo

            	 	
                          
                Nelson Liao

            
	
               Date:
                9-30-2004

            	 	
               Date:
                9-30-2004

            

    

    

    
      
        
        

      

      
        -
          5
          -Ex 10.3 WA Bio Lease Agreement

    
      Exhibit
        10.3

      

        LEASING
          AGREEMENT

        

        The
          agreement, dated May18, 2005 is by and between Washington Biotechnology
          (“Washington”), a Washington Corporation having a place of business in Seattle,
          WA, and AOB Biotech (“Tenant”) a Corporation having a place of business in
          Seattle, WA.

        

        BACKGROUND

         

        Washington
          occupies leased space including the Sixth and Seventh floors of 562 First
          Ave.
          S. Seattle, WA 98104 (the “Building”) as a result of a “master” lease agreement,
          the terms of which are incorporated into this agreement by this reference,
          between Washington and FB&P Partnership. Tenants desire to acquire use of a
          proportion of that space (the “Leased Space”), and the use of equipment residing
          in the Leased Space.

AGREEMENT

       

      	1.  	
              TERM:
                This Agreement shall have a twelve month term, beginning May 23,
                2005.

            

      

      	2.  	
              LEASED
                SPACE: The Leased Space covered under this Agreement is described
                as
                approximately one-half of the usable bench space in the laboratory
                facility known as 562 First Ave. S. #704, Seattle, WA 98104. Provision
                for
                the location of a desk and other floor-mounted items, including equipment,
                not to exceed one half of the available usable floor space will be
                made
                for Tenant’s use. Tenant will have exclusive use of this space which may
                be leased and secured against entry by third parties except for other
                Tenants repairing use of the space within #704 not leased by Tenant,
                repairs or maintenance on a scheduled or unscheduled in the case
                of
                emergency basis. Also included is shared use, on a “sign up” basis, is the
                tissue culture facility, the radioactive materials room, the
                autoclave/cleanup room, all on the 6th
                floor adjacent to the vivarium area, and the conference room on the
                7th
                floor and all other shared facilities on the Sixth and Seventh
                floors.

            

      

      	3.  	
              CO-OCCUPANCY:
                The Sixth and Seventh floors of the building will be available for
                the use
                of both Tenant and Washington with the exception of space dedicated
                to the
                sole use of either party or Sublessors. Tenant’s reasonable incidental use
                of shared areas of the Sixth and Seventh floors of the Building exclusive
                of the Leased Space will not be so as to interfere with reasonable
                business requirements of Washington or other
                Sublessors.

            

      

      	4.  	
              EQUIPMENT:
                Scientific equipment belonging to Washington, including HPLC, will
                be
                available for the reasonable use of Tenant Exceptions to this are
                equipment dedicated to the sole use of the owner of that equipment
                for
                regulatory or other statutory reasons. This clause does not apply
                to the
                use of small items of personal-type equipment such as micropipers
                and the
                like, and does not cover disposable, expendable, or single-use items,
                or
                reagents, except by subsequent agreement between the Parties. No
                guarantee
                is made regarding any specific type of equipment, nor does Washington
                warrant the rendition or usability of any equipment available for
                the use
                of Tenant, Maintenance and or repair of such equipment is the
                responsibility of the user, and not Washington. Prior reservation
                for the
                use of individual items of equipment either verbal or written (e.g.
                a
                “Sign-up” sheet), may be required by the owner of the item of equipment.
                Equipment shall be used consistent with uses for which it is required
                by
                the owner (e.g. for FDA “GMP” purposes). Damage caused to equipment
                through negligence or other actions of Tenant will be remedied by
                the
                responsible party without delay, Equipment requiring service or repair
                arising through routine use will be serviced and paid for in proportion
                to
                the use of that equipment as a result of this agreement, or by subsequent
                agreement between the Parties.

            

      

      	5.  	
              CONFIDENTIALITY,
                ETC: The Parties to this Agreement recognize the essentially confidential
                and proprietary nature of elements of each other’s business. Reasonable
                efforts will be made by the parties to this agreement to observe
                and
                protect the confidential and proprietary nature of other’s business. This
                Agreement may only be modified in writing. This represents the entire
                agreement between (LESSON) and
                Washington.

            

      

      	6.  	
              PAYMENTS:
                Tenant will pay to Washington the sum of $800 per month during the
                first
                year of the term of this agreement, due on the first day of the month
                covered under this Agreement (Tenant will also pay to Washington
                a sum
                equal to the final month’s rent which will be held by Washington on behalf
                of Tenant and will be applied to Tenant’s final month’s occupancy, or if
                claims arise from the interpretation of Item 7 below, for the satisfaction
                or partial satisfaction of those claims. Tenant also agrees to promptly
                reimburse Washington for any accidental damage caused by Tenant accepting
                normal wear and tear on the facility. Garbage collection, water,
                and
                electricity (but not telephone, internet, or other communications
                services) are provided under this lease, however, Tenant agrees to
                reimburse Washington under this agreement for a proportion of the
                cost of
                electrical service to the facility, prorated according to the square
                footage occupied by Tenant on either an exclusive or shared basis.
                Reimbursement for electrical charges will be invoiced and payable
                with the
                subsequent month’s rent. Tenant also agrees to reimburse Washington for a
                pro-rata share of common area charges, which include water usage,
                garbage
                collection, insurance, and other charges that are paid by all tenants
                of
                the building on a pro-rata basis.

            

      

      	7.  	
              HOLD
                HARMLESS, ETC.: Tenant agrees to hold harmless Washington against
                claims
                arising out of Tenant’s course of business or use of Space or Equipment as
                provided for under this Agreement or otherwise. Washington agrees
                to hold
                harmless Tenant against claims arising out of Washington’s course of
                business or use of Space or Equipment as provided by this Agreement
                or
                otherwise. Tenant agrees to follow regulatory and safety guidelines
                applicable to the nature of the Tenant business. Washington agrees
                to lend
                reasonable assistance to Tenant to support Tenant business purposes.
                Tenant will obtain liability insurance or will reimburse Washington
                for
                its proportional share of insurance if named “additional insured” on
                Washington’s insurance. Washington will not be liable for performance
                under this Agreement where non-performance is caused by “Acts of God” or
                Force Majeure or other actions of third parties that may impair
                Washington’s performance under this lease. No warranties or guarantees,
                implicit or explicit, are extended by this Agreement in addition
                to those
                specifically stated herein. In the case of a dispute arising between
                the
                parties, excepting non-payment of rent or reimbursements called for
                by
                this lease, the parties agree to settle such dispute under the auspices
                of
                an accredited arbitration service agreeable to both. If agreement
                is not
                reached between the parties on an arbitration service, such dispute
                will
                be settled by binding arbitration by the American Arbitration Association
                in Seattle, WA. Costs of arbitration will be borne by the party
                substantially not prevailing in a proportion to be decided by the
                arbitrator. Reasonable and customary collection costs will be borne
                by
                debtor in the case of default under the terms of this Agreement or
                any
                arbitrated settlement of dispute will be borne by debtor and will
                be
                collected as part of such collection. Washington agrees to work with
                Tenant to maintain cleanliness of the Leased Space and the facility
                in
                general, and agrees to share reasonable costs of cleaning and maintenance
                of the facility.

            

      

 

      For
        Washington Biotechnology

      

      

      
        	
                /s/
                  Stefan Paskell

              	
                17
                  May 2005

              
	
                Stefan
                  Paskell, President

              	
                 

              
	
                 

              	
                 

              

      

      

      

      For
        AOB
        Biotech

      

      

      
        	
                /s/
                  Eva Aw

              	
                17
                  May 2005

              
	
                Eva
                  Aw, President, Research

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]